01 1Shandong Ruiying Pioneer Pharmaceutical
01 1PIPERACILLIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-05-11
Pay. Date : 2018-03-27
DMF Number : 23614
Submission : 2010-03-11
Status : Active
Type : II
20
Shandong Ruiying Pioneer Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PIPERACILLIN, with a corresponding US DMF Number 23614.
Remarkably, this DMF maintains an Active status since its submission on March 11, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 11, 2018, and payment made on March 27, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
